Detalhe da pesquisa
1.
Impact of etoposide and ASCT on survival among patients aged <65 years with stage II to IV PTCL: a population-based cohort study.
Blood
; 140(9): 1009-1019, 2022 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35544601
2.
Outcome of combined modality treatment in first-line for stage I(E) peripheral T-cell lymphoma; a nationwide population-based cohort study from the Netherlands.
Haematologica
; 109(4): 1163-1170, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37794805
3.
Detection of circulating tumor DNA in plasma of patients with primary CNS lymphoma by digital droplet PCR.
BMC Cancer
; 24(1): 407, 2024 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38566053
4.
The value of thymus and activation related chemokine immunohistochemistry in classic Hodgkin lymphoma diagnostics.
Histopathology
; 82(3): 495-503, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36345263
5.
Work and education interruption in long-term Hodgkin lymphoma survivors: an analysis among patients from nine EORTC-LYSA trials.
Acta Oncol
; 62(7): 744-752, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37039661
6.
Navitoclax Most Promising BH3 Mimetic for Combination Therapy in Hodgkin Lymphoma.
Int J Mol Sci
; 23(22)2022 Nov 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36430230
7.
Soluble PD-L1 is a promising disease biomarker but does not reflect tissue expression in classic Hodgkin lymphoma.
Br J Haematol
; 193(3): 506-514, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33620088
8.
Combining brentuximab vedotin with dexamethasone, high-dose cytarabine and cisplatin as salvage treatment in relapsed or refractory Hodgkin lymphoma: the phase II HOVON/LLPC Transplant BRaVE study.
Haematologica
; 106(4): 1129-1137, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32273476
9.
Interim thymus and activation regulated chemokine versus interim 18 F-fluorodeoxyglucose positron-emission tomography in classical Hodgkin lymphoma response evaluation.
Br J Haematol
; 190(1): 40-44, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32106342
10.
Improved survival for adolescents and young adults with Hodgkin lymphoma and continued high survival for children in the Netherlands: a population-based study during 1990-2015.
Br J Haematol
; 189(6): 1093-1106, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32030738
11.
Successful treatment of hairy cell leukemia variant with obinutuzumab.
Ann Hematol
; 101(3): 703-704, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34086065
12.
Biomarkers for evaluation of treatment response in classical Hodgkin lymphoma: comparison of sGalectin-1, sCD163 and sCD30 with TARC.
Br J Haematol
; 175(5): 868-875, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27610595
13.
Borrelia burgdorferi mimicking central nervous system relapse in diffuse large B cell lymphoma.
Ann Hematol
; 99(12): 2947-2948, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32296911
14.
Long-Term Follow-Up of the Response-Adapted Intergroup EORTC/LYSA/FIL H10 Trial for Localized Hodgkin Lymphoma.
J Clin Oncol
; 42(1): 19-25, 2024 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37967311
15.
Treatment strategies and outcome in relapsed peripheral T-cell lymphoma: results from the Netherlands Cancer Registry.
Blood Adv
; 2024 May 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38739705
16.
Doxorubicin Exposure and Breast Cancer Risk in Survivors of Adolescent and Adult Hodgkin Lymphoma.
J Clin Oncol
; : JCO2301386, 2024 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38359378
17.
A population-based study of transformed marginal zone lymphoma: identifying outcome-related characteristics.
Blood Cancer J
; 13(1): 130, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37658062
18.
Genomic profiling of post-transplant lymphoproliferative disorders using cell-free DNA.
J Hematol Oncol
; 16(1): 104, 2023 09 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37705050
19.
A significant proportion of classic Hodgkin lymphoma recurrences represents clonally unrelated second primary lymphoma.
Blood Adv
; 7(19): 5911-5924, 2023 10 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37552109
20.
Plasma thymus and activation-regulated chemokine as an early response marker in classical Hodgkin's lymphoma.
Haematologica
; 97(3): 410-5, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22058214